Publications

Our research contributions to the scientific community

Base editing HbS to HbG-Makassar improves hemoglobin function supporting its use in sickle cell disease.

Kostamo Z et al.

Nat Commun 2025

Impact of hydroxycarbamide treatment on the whole-blood transcriptome in sickle cell disease.

Bhat V et al.

Br J Haematol 2025

Dual α-globin-truncated erythropoietin receptor knockin restores hemoglobin production in α-thalassemia-derived erythroid cells.

Chu SN et al.

Cell Rep 2025

Enhancement of erythropoietic output by Cas9-mediated insertion of a natural variant in haematopoietic stem and progenitor cells.

Luna SE et al.

Nat Biomed Eng 2024

Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes.

Patel AP et al.

JAMA Intern Med 2024

A miniaturized wash-free microfluidic assay for electrical impedance-based assessment of red blood cell-mediated microvascular occlusion.

Oshabaheebwa S et al.

Biosens Bioelectron 2024

Can we use biomarkers to identify those at risk of acute pain from sickle cell disease?

Bhat V, Sheehan VA

Expert Rev Hematol 2024

Gene Therapies for Hemoglobinopathies: Promises and Challenges.

Sheehan V

Hemoglobin 2024

Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease.

Rab MAE et al.

Blood Adv 2024

iCLOTS: open-source, artificial intelligence-enabled software for analyses of blood cells in microfluidic and microscopy-based assays.

Fay ME et al.

Nat Commun 2023

Genetic regulation of fetal hemoglobin across global populations.

Cato LD et al.

medRxiv 2023

Africa must participate in finding a gene therapy cure for sickle-cell disease.

Moshi G et al.

Nat Med 2022

Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers.

Saah E et al.

Hematol Oncol Clin North Am 2022

Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing.

Park SH et al.

Sci Adv 2022

Validation of single-gene noninvasive prenatal testing for sickle cell disease.

Westin ER et al.

Am J Hematol 2022

Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease.

Gondek LP et al.

J Clin Med 2022

Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.

Sheehan VA et al.

Br J Haematol 2022

Burden of central nervous system complications in sickle cell disease: A systematic review and meta-analysis.

Lee S et al.

Pediatr Blood Cancer 2022

OcclusionChip: A functional microcapillary occlusion assay complementary to ektacytometry for detection of small-fraction red blood cells with abnormal deformability.

Man Y et al.

Front Physiol 2022

Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without α-thalassaemia.

Boisson C et al.

Br J Haematol 2021

A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease.

Rampersaud E et al.

Blood Adv 2021

Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease.

Boisson C et al.

Cells 2021

Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells.

Cromer MK et al.

Nat Med 2021

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.

Taliun D et al.

Nature 2021

Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease.

Rab MAE et al.

Am J Hematol 2021

Methodological aspects of oxygen gradient ektacytometry in sickle cell disease: Effects of sample storage on outcome parameters in distinct patient subgroups.

Boisson C et al.

Clin Hemorheol Microcirc 2021

Concurrent Assessment of Deformability and Adhesiveness of Sickle Red Blood Cells by Measuring Perfusion of an Adhesive Artificial Microvascular Network.

Lu M et al.

Front Physiol 2021

Rheological Impact of GBT1118 Cessation in a Sickle Mouse Model.

Kanne CK et al.

Front Physiol 2021

Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.

Nielsen JB et al.

Nat Commun 2020

A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data.

Chang TC et al.

Blood Adv 2020

The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management.

Darbari DS et al.

Eur J Haematol 2020

Pediatric to Adult Transition in Sickle Cell Disease: Survey Results from Young Adult Patients.

Travis K et al.

Acta Haematol 2020

Methodological aspects of the oxygenscan in sickle cell disease: A need for standardization.

Rab MAE et al.

Am J Hematol 2020

Blood rheology biomarkers in sickle cell disease.

Lu M et al.

Exp Biol Med (Maywood) 2020

End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Farrell AT et al.

Blood Adv 2019

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.

Rab MAE et al.

J Vis Exp 2019

A novel high-throughput molecular counting method with single base-pair resolution enables accurate single-gene NIPT.

Tsao DS et al.

Sci Rep 2019

Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease.

Park SH et al.

Nucleic Acids Res 2019

Spontaneous healing of avascular necrosis of the femoral head in sickle cell disease.

Itzep NP et al.

Am J Hematol 2019

Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.

Zhang Y et al.

Blood 2018

A Retrospective Analysis of Sociodemographic and Hematologic Characteristics Associated With Achieving Optimal Hydroxyurea Therapy in Children With Sickle Cell Disease.

George PE et al.

J Pediatr Hematol Oncol 2018

Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition.

Mwesigwa S et al.

Transfusion 2018

Fetal haemoglobin induction in sickle cell disease.

Paikari A, Sheehan VA

Br J Haematol 2018

Genetic modifiers of severity in sickle cell disease.

Chang AK et al.

Clin Hemorheol Microcirc 2018

Echocardiography Differentiates Lethally Irradiated Whole-Body From Partial-Body Exposed Rats.

Inoue T et al.

Front Cardiovasc Med 2018

p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy.

Moreno-Smith M et al.

Clin Cancer Res 2017

The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.

Friedrisch JR et al.

Blood Cells Mol Dis 2016

Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease.

Summarell CC, Sheehan VA

Exp Biol Med (Maywood) 2016

Inhibition of Listeria monocytogenes in deli-style turkey breast formulated with cultured celery powder and/or cultured sugar-vinegar blend during storage at 4°c.

Golden MC et al.

J Food Prot 2014

Hepatitis C and neutropenia.

Sheehan VA et al.

Curr Opin Hematol 2014

Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia.

Sheehan VA et al.

PLoS One 2014

Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.

Sheehan VA et al.

Pediatr Blood Cancer 2013

Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.

Sheehan VA et al.

Am J Hematol 2013

Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.

Flanagan JM et al.

Blood 2013

Severe neutropenia in patients with chronic hepatitis C: a benign condition.

Sheehan V et al.

Acta Haematol 2013

Dantrolene sodium for the treatment of aldesleukin-induced rigors in a melanoma patient.

Azari LM et al.

Ann Pharmacother 2012

Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003.

Sheehan VM et al.

Microbiology (Reading) 2007

Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118.

Sheehan VM et al.

Appl Environ Microbiol 2006